China Biopsy Device Market Report by Products, Imaging Technology, End User and Company Analysis 2026-2034

China Biopsy Devices Market Size & Forecast 2026-2034

China biopsy devices market is projected to grow at a Compound Annual Growth Rate of 7.03% during the forecast period from 2026 to 2034. The biopsy devices market in China is estimated to be worth US$ 628.53 million in 2025 and is projected to reach US$ 1164.30 million in 2034. The increasing incidence of cancer and awareness about the diagnosis of cancer at an early stage are the key factors that are responsible for the growth of the biopsy devices market in the country. The increasing healthcare infrastructure and the adoption of precise diagnostic devices are also contributing to the growth of the biopsy devices market in the country.

China Biopsy Devices Market Outlooks

Biopsy devices are medical equipment that is used for collecting tissue or cell samples from the human body for examination. This examination is conducted for detecting various diseases, like cancer, infections, and other inflammatory disorders. The biopsy devices include needles, forceps, and vacuum devices. These devices are used for collecting accurate samples without causing significant discomfort to the patient. The biopsy procedures are conducted on different parts of the human body, like the breast, lung, liver, and prostate. These procedures are conducted with the help of imaging devices like ultrasound, CT scans, and MRI scans.

The popularity of biopsy devices in China is growing significantly due to the increased incidence of cancer and awareness about cancer detection. With improvements in healthcare facilities, many hospitals and diagnostic centers are increasingly adopting advanced biopsy devices for improving accuracy in diagnosis. The government is also taking steps to promote cancer detection programs and early detection through biopsy procedures. The trend towards minimally invasive procedures has increased the acceptability and popularity of biopsy procedures. The healthcare infrastructure and medical technology are improving in China, and hence, biopsy devices are likely to experience significant growth in demand.

Growth Driver of the China Biopsy Devices Market

Rising Cancer Incidence and Demand for Early Diagnosis

The rise in cancer cases in China is also fueling the market for biopsy devices. The rise in cancer cases in China is mainly because of factors such as rapid urbanization, pollution, and lifestyle changes, which have led to an increase in cancer cases, including lung cancer, breast cancer, and liver cancer. The rise in cancer cases is creating a huge demand in the market for devices used in the diagnosis of cancer, as early diagnosis of cancer is crucial in improving the survival rate of patients, and hence, patients and doctors are opting for early diagnosis of cancer through procedures such as biopsies. The government is also launching initiatives to promote cancer screening and awareness, which is also fueling the market for biopsy devices in China, as more and more people are undergoing cancer diagnosis procedures. The rise in healthcare facilities in urban and semi-urban areas is also fueling the market in China. As the significance of preventive healthcare continues to increase, the need for accurate and non-invasive biopsy equipment is expected to increase steadily in China. In China, there were approximately 364,800 new cases of liver cancer (268,900 men and 95,900 women), and approximately 318,800 liver cancer deaths (233,500 men and 85,300 women) in 2014. The Western regions of China had the highest incidence and mortality rates. The incidence and mortality rates of liver cancer in China decreased by approximately 2.3% and 2.6% annually from 2000 to 2014, and are expected to decrease by more than 44% from 2014 to 2030. The young generation, especially those younger than 40 years of age, have a steeper rate of decline.

Technological Advancements in Minimally Invasive Procedures

Technological innovation in biopsy devices is also contributing significantly to the growth of the market in China. Modern biopsy devices, including image-guided and vacuum-assisted devices, allow for precise tissue sampling with minimal discomfort and reduced complications. The integration of modern technologies, including ultrasound, CT, and MRI, has also improved the accuracy of biopsy procedures. These minimally invasive procedures have become popular among patients and healthcare professionals due to their benefits in terms of reduced recovery time and enhanced patient experience. Modern hospitals and diagnostic centers in China have also started adopting these technologies, which is contributing positively to market growth. Moreover, domestic players in the Chinese market have also started investing in R&D activities to develop cost-effective and high-quality products, thereby reducing their dependency on foreign players. Technological innovation is also contributing positively to the growth of the market in China, as it is leading to the development of automated and smart devices, thereby enhancing the efficiency of biopsy procedures. March 2025, MicroPort MedBot is delighted to declare that its Toumai SP Laparoscopic Surgical Robot has gained market approval from China's National Medical Products Administration (NMPA) (registration number: 20253010347). This revolutionary surgical robot is approved for clinical applications in various departments, including urology, general surgery, and gynecology.

Expanding Healthcare Infrastructure and Government Support

The rise in healthcare infrastructure in China and government support are key drivers for the biopsy devices market. The government has invested considerably in upgrading healthcare facilities in hospitals, establishing facilities for cancer treatment, and enhancing diagnostic services. The government's efforts in improving healthcare facilities have been significant. The government's initiatives in improving healthcare services have been beneficial for the market. The government's efforts in implementing healthcare programs have been significant. The government's initiatives in implementing healthcare programs have been beneficial for the market. The government's efforts in implementing healthcare programs have been significant. The government's initiatives in implementing healthcare programs have been beneficial for the market. Healthcare development programs in rural regions have also been beneficial for the market. Private sector participation in healthcare services and foreign direct investment have also been beneficial for the market. As China continues to focus on healthcare modernization and universal coverage, the demand for biopsy devices is likely to increase in the upcoming years. n September 2024, China's Ministry of Commerce, along with healthcare authorities, announced new policies that allow fully foreign-owned hospitals in key cities such as Beijing and Shanghai, in addition to relaxing restrictions on foreign direct investment in healthcare institutions.

Challenges of the China Biopsy Devices Market

High Cost of Advanced Biopsy Devices and Procedures

The high cost factor, which is associated with technologically advanced biopsy devices, is also posing a significant challenge in the China biopsy devices market. Though technologically advanced devices have more accuracy in results and also ensure greater comfort for patients, they also have a high cost factor. This is likely to be a major challenge in the China market, where small hospitals or healthcare facilities in less developed regions may not be able to afford technologically advanced devices. Moreover, there is also a high cost factor associated with biopsy procedures, which is likely to be an additional burden for patients. Though there is an increase in government schemes that provide insurance for patients, there is still a cost factor associated with healthcare facilities in different regions.

Uneven Healthcare Access Between Urban and Rural Areas

The unequal availability of healthcare facilities in various areas, such as rural and urban areas, is another challenge for the market for biopsy devices in China. For instance, in China, there are better facilities in cities, whereas in rural areas, there are limited medical facilities, which can affect the availability of biopsy services in those areas. Patients in rural areas may have to travel long distances to get their biopsies done, which can be inconvenient for them. Moreover, there is limited availability of skilled medical professionals in rural areas, which can affect the availability of biopsy services in those areas. Thus, there is a need for the government to improve medical facilities in rural areas, which can be helpful in increasing the availability of biopsy services in those areas.

China Needle-Based Guns Biopsy Devices Market

The market for needle-based guns biopsy devices in China is growing, considering the increasing demand for accurate and efficient medical diagnostic tools. These devices are commonly used for core needle biopsies, enabling medical professionals to collect quality samples efficiently. These devices are highly sought due to their automated or semi-automated systems, which facilitate accurate results in less time. The increasing prevalence of cancer cases is driving the market for needle-based guns biopsy devices in China, considering the importance of early-stage detection. Moreover, the increasing awareness about the use of minimally invasive medical procedures is expected to boost the demand for needle-based guns biopsy devices in China in the coming years. China is a price-sensitive market, with local players developing cost-effective alternatives for such medical devices, thus driving the market for needle-based guns biopsy devices in China.

China Biopsy Needles Devices Market

The biopsy needles devices market in China is an extremely vital sector in diagnostic medicine, especially due to an increase in the number of biopsies carried out every year. Biopsy needles are vital medical devices used in various kinds of biopsies, such as fine needle aspiration biopsy and core needle biopsy. These devices are highly versatile and affordable, which makes them accessible in almost every medical institution, ranging from larger hospitals in urban areas to smaller medical centers in regional areas. The rise in the number of people suffering from chronic health conditions, especially cancer, is also contributing to an increase in biopsy needles. Various medical devices companies are developing advanced biopsy needles with better accuracy, patient comfort, and safety. In addition, imaging devices are also being used to improve accuracy in inserting these needles. There is also an improvement in local production, which is helping to reduce costs. China is also giving importance to detecting health conditions in their citizens at an early stage.

China Lung Biopsy Devices Market

The lung biopsy devices market in China is growing at a rapid rate due to the increasing incidence of lung-related diseases. The increasing incidence of lung cancer is one of the factors that is fueling the growth of the lung biopsy devices market in the country. Lung cancer is one of the most common lung-related diseases in the country. Lung biopsy devices are used in the diagnosis of lung-related diseases. Lung biopsy devices are medical devices that are used in the diagnosis of lung-related diseases. The devices are used in the diagnosis of lung cancer and other lung-related conditions. The increasing incidence of lung-related conditions and the adoption of advanced technologies in the diagnosis of these conditions are the factors that are fueling the growth of the lung biopsy devices market in the country. The increasing awareness of the importance of lung health and the adoption of advanced technologies in the diagnosis of lung-related conditions are the factors that are fueling the growth of the lung biopsy devices market in the country.

China Biopsy CT Scan Devices Market

The market for biopsy CT scan devices in China is expanding, mainly because more and more healthcare institutions are turning to image-guided procedures to ensure accurate diagnosis of patients. The CT-guided biopsy devices help doctors locate and reach abnormal tissues in the body, especially in areas that are difficult to reach, such as the lungs, liver, and other areas of the abdomen. The use of image guidance in conjunction with biopsy procedures ensures accurate results and minimizes the chances of complications during the procedure. The rising incidence of cancer and the need to detect it in its early stages are major factors fueling the market for CT-guided biopsy devices. Moreover, improvements in CT scan technology, which now provide more accurate and quick results, are also helping to drive the market for CT-guided biopsy devices in China. Large hospitals and diagnostic centers in urban areas of the country are the major adopters of these devices, but the ongoing drive to make them available in other cities is also helping the market grow.

China Biopsy Devices Hospitals Market

Hospitals comprise the largest share in the China biopsy devices market. They are considered to be the main centers for diagnostic and treatment activities. Due to an increase in chronic health conditions such as cancer, hospitals are witnessing an increase in biopsy procedure requirements. Large hospitals are well-equipped with advanced diagnostic equipment, such as imaging-guidance biopsy devices and automated biopsy devices. Government initiatives in healthcare are also contributing to an increase in hospital infrastructure. In addition, hospitals are also benefiting from an increase in healthcare personnel, which is resulting in an improvement in patient care. Furthermore, hospitals are increasingly using advanced biopsy devices in public and private facilities, which is also contributing to an increase in the share of this segment. In addition, due to an increase in healthcare services in China, hospitals are expected to remain the main end-users of biopsy devices.

Beijing Biopsy Devices Market

The biopsy devices market in Beijing is influenced by the fact that Beijing is at the forefront in terms of healthcare and medical research in China. Beijing is known for having many top-class hospitals and medical institutions that focus on cancer diagnosis and treatment. The presence of highly qualified medical professionals and funding for medical research and development also contribute to the growth of the biopsy devices market in Beijing. The fact that Beijing is at the forefront in terms of healthcare and medical research in China also means that Beijing is at the forefront in terms of awareness about early detection and preventive care. This is likely to increase the number of people opting for biopsy procedures. The presence of international companies also means that there is likely to be technological advancement in terms of biopsy devices. Beijing is likely to remain at the forefront in terms of healthcare and medical research in China, and this means that the biopsy devices market is likely to keep growing.

Shanghai Biopsy Devices Market

The biopsy devices market in Shanghai is growing at a rapid rate due to the high emphasis placed on innovation and the well-developed healthcare system. The presence of various advanced hospitals and private healthcare services in Shanghai contributes to the growth of the biopsy devices market. The increasing number of private hospitals and clinics in Shanghai is creating healthy competition in the region. This has led to the adoption of advanced biopsy devices. The presence of an affluent population and the high per capita healthcare expenditure in Shanghai also contributes to the growth of the biopsy devices market. The presence of Shanghai as one of the top financial and economic hubs in the country attracts various international healthcare organizations. This has led to the development and availability of the latest biopsy devices in the region. The increasing awareness of the early detection of cancer and the rise in health check-ups also contributes to the growth of the biopsy devices market in Shanghai.

Tianjin Biopsy Devices Market

The market for biopsy devices in Tianjin is growing steadily, with ongoing development in healthcare infrastructure. Being an industrial hub with access to sea routes, Tianjin is developing healthcare infrastructure by building more hospitals in the region. This is in line with meeting the healthcare requirements of the population living in Tianjin. The prevalence rate of chronic diseases, including cancer, is also on the rise. This is creating demand for more biopsy procedures in the region. Healthcare facilities in Tianjin are adopting more modern technologies in biopsy procedures. Initiatives taken by the government in improving healthcare facilities in the region have also played a significant role in the development of the market. Though not at par with markets in Beijing or Shanghai, the market in Tianjin is growing steadily with more availability of high-tech medical equipment. With ongoing development in healthcare infrastructure, Tianjin is likely to see more adoption of biopsy devices in healthcare facilities.

Chongqing Biopsy Devices Market

The biopsy devices market in Chongqing is growing as the city is developing as a significant healthcare hub in western China. With its huge population and growing healthcare requirements, there is an increased need for diagnostic care, including biopsy. The central government is focusing on improving healthcare infrastructure in western China. This has led to new hospitals opening and existing ones being upgraded. This is positively contributing to increased access to highly sophisticated biopsy devices for a larger population. There is also increased awareness about early diagnosis and preventive healthcare. However, compared to cities in eastern China, Chongqing is still in need of improving its healthcare facilities in terms of easy access to highly sophisticated medical devices and specialists. However, as healthcare is improving in Chongqing, it is expected that biopsy devices will be increasingly used in the region.

Market Segments

Product

• Needle-Based Guns
• Biopsy Guidance Systems
• Biopsy Needles
• Biopsy Forceps
• Others

Application

• Breast Biopsy
• Lung Biopsy
• Prostate Biopsy
• Liver Biopsy
• Gastroenterology Biopsy
• Others

Technology

• CT Scan
• Stereotactic Guided
• Ultrasound Guided
• MRI Guided
• Others

End-User

• Hospitals
• Diagnostic & Imaging Center
• Others

City

• Beijing
• Shanghai
• Jiangsu
• Fujian
• Zhejiang
• Tianjin
• Guangdong
• Inner Mongolia
• Hubei
• Chongqing
• Rest of China

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis:

• Cardinal Health, Inc.
• Hologic, Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Medtronic plc.
• Olympus Corporation
• CONMED Corporation